Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Breast Cancer or Medication Adherence
and you are
over 18
years old
This is an advanced phase trial assessing
the effectiveness of the new treatment before being released on the market.
Show me locations

The purpose

The proposed research is a randomized controlled investigation of the efficacy of motivational interviewing (MI) to improve adherence to aromatase inhibitors (AI) in a community sample of patients with poor adherence to AIs.

Provided treatments

  • Behavioral: Motivational enhancement therapy
  • Behavioral: Attention Control
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02883361. The sponsor of the trial is University of Calgary and it is looking for 128 volunteers for the current phase.
Official trial title:
Motivational Enhancement Therapy to Improve Adherence to Aromatase Inhibitors